CURSARO, CARMELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 722
EU - Europa 262
AS - Asia 155
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 1
Totale 1.142
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 718
SE - Svezia 101
IT - Italia 66
HK - Hong Kong 53
CN - Cina 50
SG - Singapore 36
GB - Regno Unito 29
DE - Germania 21
BG - Bulgaria 11
ID - Indonesia 9
FI - Finlandia 6
LT - Lituania 6
FR - Francia 4
IE - Irlanda 4
NL - Olanda 4
CA - Canada 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
ES - Italia 2
PK - Pakistan 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BR - Brasile 1
HR - Croazia 1
JP - Giappone 1
MX - Messico 1
TH - Thailandia 1
Totale 1.142
Salva come PNG Salva come JPEG
Città #
Chandler 165
Nyköping 91
Ashburn 81
Fairfield 77
Hong Kong 52
Houston 31
Seattle 29
Woodbridge 29
Singapore 26
Wilmington 23
New York 20
Cambridge 16
Princeton 15
Ann Arbor 14
London 13
Shanghai 12
San Diego 11
Sofia 11
Beijing 9
Jakarta 9
Reggio Emilia 7
Santa Clara 7
Helsinki 6
Milan 5
Washington 5
Boydton 4
Bremen 4
Buffalo 4
Dublin 4
Modena 4
Munich 4
Amsterdam 3
Cavarzere 3
Grafing 3
Kilburn 3
Prescot 3
Secaucus 3
Augusta 2
Budrio 2
Changchun 2
Chiswick 2
Collecchio 2
Lecce 2
Mariano Comense 2
Menlo Park 2
Paris 2
Romainville 2
Toronto 2
Wandsworth 2
Acton 1
Adnan Menderes 1
Baveno 1
Bergamo 1
Bologna 1
Boston 1
Brno 1
Castel Maggiore 1
Dallas 1
Elk Grove Village 1
Istanbul 1
Jacksonville 1
Las Vegas 1
Laval 1
Leipzig 1
Los Angeles 1
Madrid 1
Olomouc 1
Pescara 1
Reggio Nell'emilia 1
Rimini 1
Rome 1
Romola 1
San Mateo 1
São Gabriel 1
Tirana 1
Tokyo 1
Turin 1
Tuxtla Gutiérrez 1
Vienna 1
Zagreb 1
Zurich 1
Totale 862
Salva come PNG Salva come JPEG
Nome #
Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: Final long-term results 103
Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: a long-term follow-up study 99
Impact of interferon therapy on the natural history of hepatitis C virus related cirrhosis 70
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 64
Quality of life of hepatitis B virus surface antigen-positive patients with suppressed viral replication: comparison between inactive carriers and nucleot(s)ide analog-treated patients 64
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis 64
Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels 63
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 63
Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B 60
Quality of life in liver transplant recipients during the Corona virus disease 19 pandemic: A multicentre study 54
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance 53
Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice 53
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 53
Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment 44
Severe acute respiratory syndrome coronavirus-2-associated cholangiopathies 44
Treatments for hbv: A glimpse into the future 43
Virological Treatment Monitoring for Chronic Hepatitis B 40
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 29
Preliminary results of thymosin-α1 versus IFN-α treatment in patients with HBeAg negative and HBV-DNA positive chronic active hepatitis 27
Indomethacin increases 2′,5′-oligoadenylate synthetase release by cultured liver tissue of patients with HCV chronic active hepatitis 27
6. A randomized controlled trial of leukocytic IFN-a vs leukocytic IFN-a plus ribavirin in chronic hepatitis C resistant to a previous recombinant or lymphoblastoid IFN treatment 24
Interferon-α plus indomethacin combined therapy in HBeAg positive chronic hepatitis B non-responder to a previous IFNα course: Results of a pilot study 21
Totale 1.162
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.789
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.789
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021133 0 0 0 0 0 0 16 13 52 2 38 12
2021/2022228 30 16 6 2 4 16 4 34 22 22 36 36
2022/2023442 47 55 45 48 38 56 12 52 68 0 12 9
2023/2024295 11 18 10 39 63 33 20 36 10 7 19 29
2024/202564 30 6 4 24 0 0 0 0 0 0 0 0
Totale 1.162